Abstract Details

Title The Efficacy of Vestibular Rehabilitation Therapy for Mild Traumatic Brain Injury: A Systematic Review and Meta-analysis

Topic Neuro-rehabilitation

Presentation(s) P12 - Poster Session 12 (5:30 PM-6:30 PM)

Poster/Presentation
Number 10-005

Objective

This systematic review and meta-analysis aim to determine the efficacy of of Vestibular Rehabilitation Therapy (VRT) as a treatment option for mTBI.

Background Mild Traumatic Brain Injury (mTBI) or concussion is a common yet undermanaged and underreported condition. It is a well-recognized cause of long-term disability resulting in physical, cognitive, and emotional damage.

Design/Methods This review and meta-analysis was performed following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. It included RCTs and pre-VRT/post-VRT retrospective chart reviews. Records meeting the inclusion criteria were extracted from the following databases: Medline, Embase, and Cochrane Register of Controlled Trials (CENTRAL).

Results Eight articles met the inclusion criteria, from which six RCTs were included in the meta-analysis. VRT demonstrated significant improvement in decreasing perceived dizziness at the end of the intervention program as shown by DHI scores (SMD= -0.33, 95% CI -0.62 to -0.03, p=0.03, I2= 0%). However, no significant reduction in DHI was evident after two months of follow-up (SMD= 0.15, 95% CI -0.23 to 0.52, p=0.44, I2=0%). Quantitative analysis also depicted significant reduction in both VOMS (SMD=-0.40, 95% CI -0.60 to -0.20, p<0.0001, I2=0%) and PCSS (SMD= -0.39, 95% CI -0.71 to -0.07, p=0.02, I2=0%) following the intervention. Lastly, there was no significant difference between intervention groups on BESS scores (SMD= -31, 95% CI -0.71 to 0.10, p=0.14, I2=0%) and return to sport/function (95% CI 0.32 to 30.80, p=0.32, I2=82%).

Conclusions

Current evidence on the efficacy of VRT for mTBI is limited. This review and analysis provide evidence that supports the role of VRT in improving perceived symptoms following concussion. There is still a need for high-quality trials evaluating the benefit of VRT using a standardized approach.

Authors/Disclosures
Ammar Aljabri, Jr. (King Saud bin Abdulaziz University for Health and Sciences) PRESENTER	Mr. Aljabri has nothing to disclose.
	No disclosure on file
	No disclosure on file
Omar Alageely	Mr. Alageely has nothing to disclose.
	No disclosure on file

��ɫ��

��ɫ��